We are live on
!
Find out more
SGH
Sivik Global Healthcare Portfolio holdings
AUM
$132M
1-Year Est. Return
24.1%
This Fund
S&P 500
This Quarter
Est. Return
+16.66%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$213M
AUM Growth
+$32.7M
(+18%)
Cap. Flow
+$5.62M
Cap. Flow
% of AUM
2.65%
Top 10 Holdings %
Top 10 Hldgs %
40.38%
Holding
46
New
5
Increased
12
Reduced
13
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$13.3M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$4.57M |
| 3 |
Icon
ICLR
|
+$2.97M |
| 4 |
Globus Medical
GMED
|
+$2.57M |
| 5 |
Moderna
MRNA
|
+$2.13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$3.89M |
| 2 |
Johnson & Johnson
JNJ
|
+$3.88M |
| 3 |
Medtronic
MDT
|
+$2.42M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$2.12M |
| 5 |
UnitedHealth
UNH
|
+$2.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 93.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Vertex Pharmaceuticals
VRTX
$133B
| $4.33M | 2.04% |
+15,000
| New | +$4.57M |
|
|
27
UnitedHealth
UNH
$364B
| $4.24M | 1.99% |
8,000
-4,000
| -33% | -$2.12M |
|
28
Elevance Health
ELV
$86.6B
| $4.1M | 1.93% |
8,000
-3,000
| -27% | -$1.52M |
|
29
Option Care Health
OPCH
$3.57B
| $3.91M | 1.84% |
130,000
+20,000
| +18% | +$621K |
|
30
IQVIA
IQV
$39.8B
| $3.07M | 1.45% |
15,000
+5,000
| +50% | +$1.01M |
|
|
31
Icon
ICLR
$12.9B
| $2.91M | 1.37% |
+15,000
| New | +$2.97M |
|
32
Revvity
RVTY
$13.2B
| $2.8M | 1.32% |
20,000
-5,000
| -20% | -$673K |
|
|
33
Globus Medical
GMED
$11.5B
| $2.8M | 1.32% |
+37,745
| New | +$2.57M |
|
34
Biogen
BIIB
$30.9B
| $2.77M | 1.3% |
10,000
| – | – |
|
|
35
Johnson & Johnson
JNJ
$629B
| $2.65M | 1.25% |
15,000
-22,500
| -60% | -$3.88M |
|
|
SEM
36
DELISTED
Select Medical
SEM
| $2.48M | 1.17% |
185,600
-55,680
| -23% | -$720K |
|
|
37
Moderna
MRNA
$25.4B
| $2.33M | 1.1% |
+13,000
| New | +$2.13M |
|
38
BioNTech
BNTX
$23.3B
| $1.95M | 0.92% |
+13,000
| New | +$2M |
|
|
SGEN
39
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.67M | 0.79% |
13,000
+3,000
| +30% | +$387K |
|
|
AMED
40
DELISTED
Amedisys
AMED
| – | – |
-17,500
| Closed | -$1.69M |
|
41
Avantor
AVTR
$9.42B
| – | – |
-100,000
| Closed | -$1.96M |
|
|
42
Centene
CNC
$33.1B
| – | – |
-50,000
| Closed | -$3.89M |
|
|
EHAB
43
DELISTED
Enhabit
EHAB
| – | – |
-62,594
| Closed | -$879K |
|
44
Incyte
INCY
$24.5B
| – | – |
-18,755
| Closed | -$1.25M |
|
|
45
Medtronic
MDT
$116B
| – | – |
-30,000
| Closed | -$2.42M |
|
46
Royalty Pharma
RPRX
$26.4B
| – | – |
-45,008
| Closed | -$1.81M |
|
Similar funds
AFP
PCGDR
ACM
9C
STFP
ADEF
AC
CIP
Sivik Global Healthcare's Q4 2022 Portfolio in Review
As of Q4 2022, Sivik Global Healthcare held 46 positions worth $213M, up 18% from $180M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Sivik Global Healthcare's Q4 2022 filing shows 5 new, 12 increased, 13 reduced and 7 closed positions. Its largest new stake was Vertex Pharmaceuticals: 15,000 shares worth $4.33M. The largest sale was Centene, an estimated $3.89M.
By sector, the portfolio is most concentrated in Healthcare at 93% of assets, down from 100% a quarter earlier.
- Sivik Global Healthcare's largest Q4 2022 buy was Vertex Pharmaceuticals: 15,000 shares worth $4.33M.
- Sivik Global Healthcare added most to State Street SPDR S&P Biotech ETF in Q4 2022, an estimated $13.3M increase.
- Sivik Global Healthcare's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $3.88M.
- Sivik Global Healthcare fully exited Centene in Q4 2022, selling an estimated $3.89M.
- Sivik Global Healthcare's ten largest holdings make up 40% of its $213M portfolio in Q4 2022.
- Sivik Global Healthcare opened 5 new positions and closed 7 in Q4 2022.
- Sivik Global Healthcare's portfolio value rose 18% quarter-over-quarter to $213M.
Based on Sivik Global Healthcare's 13F filing for Q4 2022, filed 8 Feb 2023.